Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer's disease.

Can ZhouFantian ZengHaijun YangZeying LiangGuanyu XuXiao LiXingdang LiuJian Yang

Published in: European journal of nuclear medicine and molecular imaging (2024)

Although NIR-II theranostic agents showed the great potential in diagnosis and treatment of AD, there are still many challenges: 1) Faborable NIR-II fluorohpores are still lacking; 2) Biocompatibility, bioseurity and dosage of NIR-II theranostic agents should be further revealed; 3) New equipment and software associated with NIR-II imaging system should be explored.

Keyphrases

photodynamic therapy
fluorescence imaging
drug release
fluorescent probe
high resolution
single cell
risk assessment
human health
iron oxide